CRVO
CervoMed Inc.
NASDAQ: CRVO · HEALTHCARE · BIOTECHNOLOGY
$3.69
+1.10% today
Updated 2026-04-30
Market cap
$35.92M
P/E ratio
—
P/S ratio
8.97x
EPS (TTM)
$-2.98
Dividend yield
—
52W range
$4 – $12
Volume
0.1M
CervoMed Inc. (CRVO) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | — | — | $-505950.00 | $-1.06M | $-1.98M | $-12.02M | $-4.31M | $-1.18M | $-9.03M | $-5.19M | $-10.77M | $-12.33M | $-10.77M | $-9.86M | $-13.55M | $-14.50M | $-2.57M | $-7.45M | $-16.53M | $-23.45M |
| Capital expenditures | $0.00 | $0.00 | $0.00 | $1122.00 | $13636.00 | $125000.00 | $0.00 | $0.00 | $50911.00 | $40291.00 | $2331.00 | $447823.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.00 | $3.00 | $3.00 | $0.00 |
| Depreciation | — | — | $55852.00 | $47204.00 | $49672.00 | $119805.00 | $164043.00 | $118306.00 | $566262.00 | $8268.00 | $25342.00 | $67981.00 | $110371.00 | $97915.00 | $103168.00 | $93416.00 | $26114.00 | — | — | — |
| Stock-based comp | — | — | — | $158149.00 | $1.36M | — | $3.77M | $2.23M | $1.61M | $594175.00 | — | — | — | $580302.00 | $736119.00 | $897260.00 | $333835.00 | $407632.00 | $1.41M | $1.45M |
| Free cash flow | — | — | $-505950.00 | $-1.06M | $-1.99M | $-12.15M | $-4.31M | $-1.18M | $-9.08M | $-5.23M | $-10.77M | $-12.78M | $-10.77M | $-9.86M | $-13.55M | $-14.50M | $-2.57M | $-7.45M | $-16.53M | $-23.45M |
| Investing cash flow | — | — | — | $-213122.00 | $-1.38M | $-985893.00 | — | — | $-50911.00 | $2.46M | $8.50M | $-447823.00 | — | — | — | $4000.00 | $-12.24M | — | $-28.66M | — |
| Financing cash flow | — | — | $506554.00 | $1.27M | $3.37M | $13.11M | $4.52M | $1.13M | $30.71M | $2.39M | $1.83M | $20.12M | $9.87M | $16.04M | $17.89M | $33.30M | $5000.00 | $11.15M | $46.40M | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |